SYBXSynlogic, Inc.
Synlogic, Inc. does not have significant operations. It was previously engaged in the discovery and development of synthetic biotics to treat metabolic diseases. Synlogic, Inc. is based in Winchester, Massachusetts.
Industry Peers
Biotechnology| Headline | Source | Time |
|---|---|---|
Older | ||
 Synlogic and Caldera sign merger agreement The financing supports Phase II clinical development of CLD-423 in ulcerative colitis and Crohn’s disease. | ||
 Synlogic and Caldera sign merger agreement The financing supports Phase II clinical development of CLD-423 in ulcerative colitis and Crohn’s disease. | ||
 Synlogic and Caldera Therapeutics Announce Merger and $278 Million Private Placement The merger will create a publicly traded company focused on advancing Caldera’s lead inflammatory bowel disease therapy, with financing expected to fund operations into 2029. Key Investor TakeawaysSynlogic (USOTC:SYBX) agreed to merge with privately held Caldera Therapeutics in an all-stock transaction to create a new public company. | ||
 Caldera, Vidya add to recent flurry of biotech mergers The startups are part of a surge of young companies equipped with advanced drug prospects and quickly pivoting to the public markets. | ||